Cargando…
Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension
This study assessed the efficacy and safety of sacubitril/valsartan in 23 hemodialysis patients with hypertension (mean age 70 years; male 69.6%) after switching from azilsartan, an angiotensin receptor blocker. Both at baseline and 3 months after the start of sacubitril/valsartan treatment, home bl...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994168/ https://www.ncbi.nlm.nih.gov/pubmed/36722379 http://dx.doi.org/10.1111/jch.14635 |